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ABSTRACT
Introduction: Investigators from Kaiser Permanente developed a risk-assessment calculator as a tool for evaluation of early-onset
sepsis (EOS) to narrow antibiotic use for the treatment of EOS. The integration of the EOS risk calculator into an electronic health
record will minimize manual calculations and data entry and improve compliance and accuracy through automation. Methods: We
performed a retrospective chart review for neonates ≥34 weeks and 0 days gestational age. We collected data pre-integration and
post-integration of the EOS risk calculator. The primary outcome measure is the accuracy of user input into the calculator. Secondary
outcomes include compliance with using the EOS risk calculator, impact on clinical recommendation when incorrectly calculated,
assessment of antibiotic utilization rate (AUR), and comparison of EOS risk calculator recommendations with Centers for Disease
Control and American Academy of Pediatrics recommendations. Results: Miscalculations occurred in 52% of instances pre-integration and 19% of instances post-integration; P < 0.001. Compliance was 93% pre-integration and 98% post-integration; P = 0.138.
Clinical recommendations were changed for 21% (13/62) of miscalculations pre-integration and 4% (1/23) of miscalculations post-integration; P = 0.099. The AUR for combined NICU and nursery patients was 47 pre-integration and 47 post-integration; P > 0.999.
Six cases of culture-positive sepsis were identified, and all recommendations generated by the EOS risk calculator were in alignment
with current Centers for Disease Control/American Academy of Pediatrics treatment guidelines. Conclusions: Integration of the
EOS risk calculator into the electronic health record significantly increased calculator accuracy, although it did not show statistically
significant differences with regards to compliance, clinical recommendations, or AUR. (Pediatr Qual Saf 2019;4:e235; doi: 10.1097/
pq9.0000000000000235; Published online November 6, 2019.)

INTRODUCTION

EOS.1,3 These guidelines recommend empiric antibiotic
initiation for all neonates who appear clinically ill at
birth or who are born to a woman diagnosed
with chorioamnionitis.
Consequences of early antibiotic exposure
within the neonatal population include the
development of necrotizing enterocolitis
and invasive candidiasis as well as alterations in the microbiome, illustrating the
importance of determining an objective
method to risk-stratify neonates more narrowly.4–6 A movement referred to as “Triple
I,” intrauterine inflammation, infection, or both,
has been one proposed method of reducing unnecessary antibiotic exposure within neonates by utilizing a
more objective approach to diagnose maternal chorioamnionitis.7 A multivariate prediction model was developed
to better assess the true risk of EOS development within
the neonatal population.8–10 This approach takes into
account both maternal and neonatal objective data rather
than relying exclusively on subjective findings, such as the
presence or absence of neonatal clinical illness or maternal
chorioamnionitis.
Studies utilizing this method have demonstrated a
decrease in antibiotic exposure to uninfected neonates,
blood culture draws with similar incidence rates of culture-positive sepsis, and no statistical difference in adverse
events when compared with the CDC/AAP guidelines.11–13

Neonatal early-onset sepsis (EOS) is defined as the
onset of sepsis within the first 72 hours of life.1
Group B Streptococci (GBS) or Escherichia
coli that colonize the maternal gastrointestinal or genitourinary tract are the
most common pathogens responsible for
the development of EOS.2 Until recently,
guidelines published by the Centers for
Disease Control and Prevention (CDC)
and the American Academy of Pediatrics
(AAP), have been the gold standard resource
utilized by clinicians for the management of
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A previous study within our 2 healthcare centers identified a 69% reduction in recommended empiric antibiotics
with the implementation of the EOS risk calculator.11 In
another study, implementation of the EOS risk calculator
reduced empiric antibiotic use for EOS by 42%.13 These
findings suggest that applying this risk calculator is a safe
approach that can be utilized within this clinical setting to
reduce the number of uninfected neonates administered
empiric antibiotics.
The value of the integration of decision-making tools
directly into the electronic health record (EHR) has been
previously reported. A recent study integrated and then
further improved integration of a decision-making tool
into the EHR resulting in improved utilization of the decision-making tool and a decrease in frequency of antibiotic prescribing.14 McGinn et al successfully integrated
a decision-making tool into an EHR, which resulted in
improved compliance, a reduction in antibiotic utilization, and reduction in point-of-care testing.15 Another
study evaluating the integration of a decision-making tool
resulted in a significant decrease in unnecessary testing,
with no associated increase in clinically important misdiagnoses or a decrease in physician satisfaction.16
Initial implementation of the EOS risk calculator within
our healthcare system required manual data entry of patient information into the EOS risk calculator. Clinicians
accessed the EOS risk calculator (https://neonatalsepsiscalculator.kaiserpermanente.org/) through a direct link
incorporated within the EHR. Utilization of the EOS
risk calculator resulted in increased workload, noncompliance, and miscalculations, leading to suboptimal utilization of the EOS risk calculator tool. Approximately
1 year following implementation, we integrated the EOS
risk calculator directly into the EHR to automate the process and minimize the need for manual data collection
and imputation.
The objective of this study is to evaluate the impact of
the integration of the EOS risk calculator into the EHR.
As above, many studies have validated the utility of implementation of this decision-making tool but have not
compared the accuracy, compliance, the impact of imputation errors, or difference in antibiotic utilization rates
(AURs) of the manual imputation of patient-specific data
into the EOS risk calculator to an automated process. We
hypothesize that the integration of the EOS risk calculator into the EHR will minimize manual data entry for
calculation and improve compliance, accuracy, and antibiotic utilization through automation.

to October 2017 and 6 months of data collected postEOS risk calculator integration from December 2017 to
May 2018. This study was compliant with the Guidelines
for Human Experimentation from the US Department of
Health and Human Services and received approval from
the Institutional Review Board. All data collected were
de-identified to maintain the confidentiality of all study
subjects, and no informed consent was required due to
the nature of the study design.
The patient population was generated through Epic
and Tableau reporting systems, and we completed the
chart review for each patient and the patient’s mother.
Data were collected pre-integration and post-integration
of the EOS risk calculator. A total of 20 patients were
randomly selected and evaluated each month (10 from
NICU, 10 from nursery).
To assess for the primary and secondary study objectives, we included in the neonatal data collection total admission days, gestational age, risk calculator score, clinical
illness, and blood culture and susceptibilities. Maternal
data collection included intrapartum temperature, duration of rupture of membranes, vaginal versus cesarean delivery, GBS status, and administration of perinatal GBS
prophylaxis. Signs and symptoms of clinical illness were
abstracted, and we classified patients as having a clinical
illness, equivocal appearance, or well-appearing status
according to documentation by medical providers and
definitions described by risk calculator authors (available
at https://neonatalsepsiscalculator.kaiserpermanente.org/
classification.aspx). We calculated neonatal sepsis risk per
1,000 live births using a baseline incidence of 0.3 cases
of sepsis per 1,000 live births, as this is closest to our
healthcare system EOS rate of 0.26 cases of sepsis per
1,000 live births reported in 2015. EOS risk calculator
recommendations for empiric antibiotics, blood cultures,
and vital sign monitoring according to clinical status were
recorded for each subject.
The primary outcome measure is the accuracy of the
EOS risk calculator imputation. Secondary outcomes include compliance with the utilization of the EOS risk
calculator, impact on clinical recommendation when
incorrectly calculated, assessment of AUR (antibiotic
days/1,000 patient admission days), and comparison
of EOS risk calculator recommendations with CDC/
AAP recommendations for all positive EOS cultures.
Statistical analysis was completed using Fisher’s Exact
Test. A resulting P value < 0.05 was considered statistically significant.

Implementation of the EOS Risk Calculator

METHODS

The healthcare system’s Women and Children Clinical
Performance Group assembled a Triple I and Early Onset
Sepsis Workgroup in December 2015 to improve the
identification of infants at risk for EOS. In May 2016,
the Workgroup established the utilization of the EOS risk
calculator and incorporated a link to the EOS risk calculator website into the EHR. Also, the EOS risk calculator

Study Design

We conducted a retrospective observational review of
neonates older than 34 weeks and 0 days gestational age
within 2 large tertiary teaching hospitals. A total of 12
months of data were extracted with 6 months of data collected pre-EOS risk calculator integration from May 2017
2
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infection screening parameters and nurse process instructions were added to the EHR newborn admission order
set. A Triple I/Early Onset Sepsis Toolkit providing EOS
risk calculator education was finalized in August 2016
and distributed in September 2016. Additional EOS risk
calculator education was provided to Neonatal Nurse
Practitioners at both Hospital A and Hospital B during
September 2016. An EOS risk calculator “help card” was
created and utilized by staff in Hospital B for calculator
data imputation. Copies of the “help card” were placed at
every computer workstation. Hospital B utilized a Nurse
Clinical Educator to provide EOS risk calculator education to nursing staff within the nursery unit. EOS risk calculator utilization began in October 2016 in Hospital A,
and November 2016 in Hospital B. An EOS risk calculation was to be performed following delivery on every neonate delivered older than 34 weeks and 0 days gestational
age regardless of symptoms. Implementation of the EOS
risk calculator required manual data collection and imputation of patient-specific data by the end-user (labor nurse
or provider). Staff manually documented the EOS risk at
birth score determined by the EOS risk calculator in the
EHR newborn delivery summary. Providers were notified
if the calculated EOS risk score was >0.65/1,000 births or
if the EOS risk calculator recommended the acquisition
of a blood culture.

within the EHR newborn delivery summary, reviews the
patient-specific data automatically collected for EOS risk
calculation, and accepts the resulting EOS risk score into
the patient EHR. The EOS risk score and patient-specific
data are displayed in both the maternal and neonatal
patient EHR. A smart link was developed to include
the EOS risk score into progress note documentation.
Nursing staff continued to notify providers if the calculated EOS risk score was >0.65/1,000 births or if the
EOS risk calculator recommended the acquisition of a
blood culture.

RESULTS
We identified a total of 252 patients during the 12-month
study period. EOS Risk Calculator data were incorrectly
input by users in 52% of instances pre-integration, and
the EOS risk calculator data were either auto-populated
incorrectly or adjusted by users incorrectly in 19% of
instances post-integration (P < 0.001). When we characterized results further, there was not a statistically significant difference in miscalculations for Hospital A NICU
(P = 0.2882). The EOS risk calculator was utilized in
93% of patients pre-integration and 98% of patients
post-integration (P = 0.138). EOS risk calculator clinical recommendations were changed for 21% (13/62) of
miscalculations pre-integration and 4% (1/23) of miscalculations post-integration (P = 0.099). One patient
(1/13) pre-integration had a changed clinical recommendation due to the EOS risk calculator miscalculation and classification category (Table 1). The resulting miscalculation recommended a blood culture and
CBC, whereas a correct calculation recommended no
culture and no antibiotics with routine vitals monitoring. The remaining 12 patients had no change in clinical
recommendation, despite a miscalculation. The most
commonly associated reasons for score miscalculations
pre-integration and post-integration included incorrect

Integration of the EOS Risk Calculator

In November 2017, the healthcare system informatics/
application analyst team integrated the EOS risk calculator into the EHR. This integration provided automation and standardization to the EOS risk calculation. The
Workgroup provided updated EOS risk calculator education to all staff. Hospital B continued to utilize a Nurse
Clinical Educator to provide education to nursing staff
within the nursery unit.
Following newborn delivery, the end-user calculates
the EOS risk score using the EOS risk calculator located
Table 1. Impact of Integration of Neonatal EOS Risk Calculator
Location
NICU+nursery
NICU
Nursery
Hospital A NICU
Hospital B NICU
Hospital A Nursery
Hospital B Nursery

Compliance, N (%)
Incorrect calculation, N (%)
Clinical recommendation changed, N (%)
Compliance, N (%)
Incorrect calculation, N (%)
Clinical recommendation changed, N (%)
Compliance, N (%)
Incorrect calculation, N (%)
Clinical recommendation changed, N (%)
Compliance, N (%)
Incorrect calculation, N (%)
Clinical recommendation changed, N (%)
Compliance, N (%)
Incorrect calculation, N (%)
Clinical recommendation changed, N (%)
Compliance, N (%)
Incorrect calculation, N (%)
Clinical recommendation changed, N (%)
Compliance, N (%)
Incorrect calculation, N (%)
Clinical recommendation changed, N (%)

3

Pre-Integration

Post-Integration

120 (93.0%)
62 (51.7%)
13 (21.0%)
60 (90.9%)
29 (48.3%)
8 (27.6%)
60 (95.2%)
33 (55%)
5 (15.2%)
30 (93.8%)
14 (46.7%)
4 (28.6%)
30 (88.2%)
15 (50%)
4 (26.7%)
30 (96.8%)
17 (56.7%)
0 (0%)
30 (93.8%)
16 (53.3%)
5 (31.3%)

119 (97.5%)
23 (19.2%)
1 (4.3%)
60 (96.8%)
14 (23.3%)
1 (7.1%)
60 (98.4%)
9 (15%)
0 (0%)
30 (93.8%)
9 (30%)
0 (0%)
30 (100%)
5 (16.7%)
1 (20%)
30 (100%)
3 (10%)
0 (0%)
30 (96.8%)
6 (20%)
0 (0%)

P
0.138
<0.001
0.099
0.2753
0.0073
0.2307
0.619
<0.00001
0.5671
1
0.2882
0.1273
0.1161
0.0127
1
1
0.0003
1
1
0.015
0.2663
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DISCUSSION

Table 2. Reasons for EOS Risk Calculator Score
Miscalculations

In this retrospective analysis, the EHR integration of the
Kaiser Permanente neonatal EOS risk calculator significantly increased calculator accuracy. The integration of
the EOS risk calculator resulted in an insignificant increase in calculator utilization and an insignificant decrease in the occurrence of changed clinical recommendations following miscalculations. Only 1 patient with a
miscalculation was directly impacted by the changed clinical recommendation after categorization of the clinical
presentation following examination. All other patients
with a miscalculation, which resulted in a changed clinical recommendation, were not directly impacted. For
these patients, the changed clinical recommendation was
not for the specific clinical presentation classification that
categorized these patients following clinical examination.
In a recent study, EOS risk calculator integration
increased compliance from 59% to 85% and decreased
the frequency of antibiotic prescribing from 7% to 1%.14
Within the study, the EOS risk calculator was integrated
and then improved, but was not fully automated. We attribute our higher pre-integration utilization percentage
to extensive education and guidance provided from a developed Triple I/Early Onset Sepsis Toolkit distributed
throughout our entire healthcare system before EOS risk
calculator implementation.
Accuracy in the utilization of the EOS risk calculator as
a clinical decision-making tool in the setting of neonatal
EOS is imperative. The utility of the tool decreases if not
appropriately utilized, and inaccuracies may directly influence the management of a neonate with possible EOS.
Incorrect utilization of this tool has the potential to inappropriately identify cases of EOS, leading to missed cases
of true EOS as well as inappropriate antibiotic utilization
and laboratory monitoring.
Hospital B provided staff education, a calculator “help
card,” and utilized a Nurse Clinical Educator within the
nursery unit during both pre- and post-EOS risk calculator integration phases. In the Hospital B nursery unit, a
pharmacist reviewed identified calculator errors post-EOS
risk calculator integration. A Nurse Clinical Educator
provided education to individual staff. Select cases of
identified errors were also reviewed by the healthcare

Score
miscalculations
(%)

Miscalculation
Highest MAT (°F)
Duration of ROM (h)
IAP Given
GBS status
Unknown

35
31
15
14
5

MAT, maternal antepartum temperature; ROM, rupture of membranes; IAP, intrapartum antibiotic prophylaxis.

Table 3. Antibiotic Utilization Rate

Location
NICU
Nursery
NICU+Nursery

Pre-Integration
AUR (antibiotic
days per 1,000
patient-days)

Post-Integration
AUR (antibiotic
days per 1,000
patient-days)

P

164
13
47

169
11
47

0.729
0.377
>0.999

evaluation of highest maternal temperature (35%), duration of rupture of membranes (31%), timing/type
of intrapartum antibiotics (15%), and maternal GBS
status (14%) (Table 2).
We calculated the AUR from an identified 10,558 patient admission days with a total of 498 days of antibiotic
therapy pre-integration and 10,119 patient admission
days with a total of 477 antibiotic therapy days post-integration. The AUR for combined NICU and nursery
patients was 47 pre-integration and 47 post-integration (P > 0.999). For NICU patients, the AUR was 164
pre-integration and 169 post-integration (P = 0.729). For
nursery patients, the AUR was 13 pre-integration and 11
post-integration (P = 0.377, Table 3).
We identified 6 cases of confirmed culture-positive
sepsis throughout the 12-month study period. All recommendations generated by the EOS risk calculator for each
of the 6 cases of culture-positive sepsis identified were
in alignment with recommendations from current CDC/
AAP treatment guidelines for the initiation of empiric
antibiotics (Table 4).
Table 4. Incidence of Culture-Positive Sepsis
Patient (n = 6)
Gestational Age (wk + d)
Highest MAT (°F)
Duration of ROM (h)
GBS status
IAP given
Patient clinical status
Risk of EOS based on
patient clinical status
Neonatal sepsis calculator
recommendations
CDC/AAP recommendations

1
41 + 4
100.7
16
Unknown
None
Clinical illness
19.07

2
37 + 6
98.6
21
Negative
None
Clinical illness
2.98

Empiric antibiotics Strongly consider
antibiotics
Empiric antibiotics Empiric antibiotics

3
39 + 0
100.4
12
Negative
None
Clinical illness
8.96

4
39 + 2
102.7
14
Negative
None
Clinical illness
65.04

5
34 + 1
99
197
Negative
None
Clinical illness
130.89

6
34 + 1
99.1
322
Positive
None
Clinical illness
252.15

Empiric antibiotics Empiric antibiotics Empiric antibiotics Empiric antibiotics
Empiric antibiotics Empiric antibiotics Empiric antibiotics Empiric antibiotics

MAT, maternal antepartum temperature; ROM, rupture of membranes; IAP, intrapartum antibiotic prophylaxis.
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system analyst team. We found that both Hospital A and
Hospital B nursery units had similar rates of miscalculations pre-integration. Hospital A nursery unit showed a
greater improvement in miscalculations post-integration,
further confirming the necessity for EOS risk calculator
integration to improve calculator accuracy.
We have identified several limitations of this study. First,
the monthly evaluation of EOS risk calculator results was
only from a small portion of neonates. Systematic evaluation in a prospective fashion of a larger population would
help further identify the impact of EOS risk calculator
miscalculations. There are also multiple limitations to the
integration of the EOS risk calculator itself. With the integration, maternal and neonatal information is automatically collected and displayed for the user, but within our
healthcare centers, there is still an opportunity for individual data manipulation by the user before acceptance
of results. Providing education to healthcare providers on
how to appropriately utilize any decision-making tool is
paramount.
Within both Hospital A and Hospital B, the most common miscalculations were due to incorrect imputation
of the highest maternal antepartum temperature and the
duration of rupture of membranes. The EOS risk calculator requires the entry of 6 variables to perform a risk
calculation. Without proper education, these variables
can be incorrectly input, resulting in a miscalculation of
the EOS risk score and possible incorrect clinical recommendation. The first variable, the incidence of EOS, has
12 possible incidence rates from which to select. This list
allows a hospital or healthcare system to select an EOS
incidence rate closely matching their own. Our healthcare system uses an EOS incidence rate of 0.3/1,000 live
births, and following EOS risk calculator implementation, required the end-user to select the correct EOS incidence rate manually. The incidence rate of 0.5/1,000 live
births listed within the EOS risk calculator selection menu
states “CDC national incidence” and has led to confusion
among some end-users who were unaware of our healthcare system EOS incidence rate. Following EOS risk calculator integration, the calculator automatically defaults
the EOS incidence rate to 0.3/1,000 live births.
Gestational age is recorded in the EOS risk calculator
as weeks and days, with a range of 34 to 43 weeks. The
EOS risk calculator will not calculate an EOS risk score
if clinicians enter a gestational age outside of this range.
With EOS risk calculator integration, gestational age correctly auto-populates both fields and will not calculate if
the gestational age is outside the defined range.
Implementation of the EOS risk calculator required the
end-user to review numerous days of chart documentation to identify the highest recorded maternal antepartum
temperature within an appropriate time frame. With EOS
risk calculator integration, the highest maternal antepartum temperature within the previous 7 days before
delivery is now auto-populated into the EOS risk calculator. Following integration, we have identified instances

where the end-user overrode the auto-populated highest
maternal antepartum temperature and selected a temperature recorded either beyond 7 days before delivery or
during the postpartum period.
During the implementation phase of the EOS risk calculator, end-users would often enter or round the duration of rupture of membranes incorrectly. This problem
was resolved with the integration of the EOS risk calculator as the automated EOS risk calculator auto-populates the duration of the rupture of membranes input field
with information from the delivery summary.
With EOS calculator implementation, the end-user was
required to determine maternal GBS status and correctly
select negative, positive, or unknown within the EOS risk
calculator. The EOS risk calculator “help card” used at
Hospital B instructed the end-user to select maternal GBS
status unknown if a negative GBS culture was drawn
older than 5 weeks before the time of delivery. This recommendation is in agreement with revised CDC guidelines, which state the negative predictive value of GBS
cultures declines if performed older than 5 weeks before
delivery.3 Following EOS calculator integration, automation incorporates the 5-week GBS collection timeframe
into the maternal GBS status decision-making process.
We have identified instances post-integration where the
maternal GBS status was adjusted by the end-user from
unknown to negative based on progress note documentation or GBS culture result regardless of being reported as
negative older than 5 weeks from time of delivery.
Education on the selection of intrapartum antibiotics
was provided in the Triple I/Early Onset Sepsis Toolkit
distributed across the entire healthcare system. Additional
information was provided within the EOS risk calculator
“help card” utilized at Hospital B. One challenge identified following the implementation of the EOS risk calculator was the proficiency of the end-user to appropriately
classify antibiotics and/or antibiotic combinations as either GBS specific or broad-spectrum antibiotics. Also, the
end-user had to consider the timing of antibiotic administration. With the integration of the EOS risk calculator,
automation correctly identified intrapartum antibiotic
classification based on the type of antibiotics and the timing of antibiotic administration. We identified instances
post-integration where end-users adjusted the type of
intrapartum antibiotics selected through the automation
process.
There was no significant change in the AUR throughout
the study period pre- and post-integration of the EOS risk
calculator. Additionally, in all 6 cases of confirmed culture-positive sepsis, the EOS risk calculator recommended
utilization of antibiotics consistent with the CDC/AAP
guideline criteria, and correctly identified true cases of
infection.
EOS of the newborn remains a challenging clinical dilemma due to its relative rarity, high mortality, and lack
of highly specific biomarkers. The integration of the
Kaiser Permanente neonatal EOS calculator as a clinical
5
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tool into the EHR significantly reduces the number of
miscalculations.
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